Stay updated on Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial

Sign up to get notified when there's something new on the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the primary endpoint of the study related to insulin degludec titration using the Glooko Mobile Insulin Dosing System for type 2 diabetes management.
    Difference
    0.1%
    Check dated 2024-06-06T14:31:19.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying the requirements for inclusion and exclusion, such as the ability to sign an informed consent form and specific health conditions. Previously, this section only indicated that no information was provided.
    Difference
    22%
    Check dated 2024-05-22T20:53:28.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T21:55:53.000Z thumbnail image

Stay in the know with updates to Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page.